SCHEMBL9340928

SCHEMBL9340928

CCCCc1cccc(=O)n1Cc1ccc(NC(=O)c2ccccc2C#N)cc1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.43
AGTR2 P50052 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9339133 0.83 TSHR (0.47)
SCHEMBL9339131 0.80
SCHEMBL9337497 0.79 PPARG (0.56) AGTR1AGTR2
SCHEMBL9337200 0.77 TSHR (0.43) AGTR1
SCHEMBL9339293 0.76 ATM (0.38)
SCHEMBL9337412 0.76 PPARG (0.55) AGTR1AGTR2
SCHEMBL9341437 0.74 FFAR1 (0.49)
SCHEMBL9337724 0.74 PLK1 (0.62) AGTR1
SCHEMBL9402342 0.74
SCHEMBL16088655 0.73 TRPV1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332750-A Treatment of hypertension, aldosteronism, cardiac insufficienc y MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-07-26 US disclosed
EP-0530702-A1 1,2-dihydro-2-oxopyridines as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-03-10 EP disclosed